Litman Gregory Wealth Management’s BlackRock Health Sciences Trust BME Stock Holding History
Bought
Maintained
Sold
Other funds holding BME
SWP
FAAS
Litman Gregory Wealth Management's BME Position: Q1 2017 in Review
Litman Gregory Wealth Management sold out of BlackRock Health Sciences Trust (BME) in Q1 2017, closing a stake of 853 shares — an estimated $27K sold.
Litman Gregory Wealth Management first reported a position in BME in Q1 2016 and held it in 4 quarters. The position peaked at $57K in Q2 2016. 27 funds tracked by Wall St. Rank hold BME as of Q1 2017.
- Litman Gregory Wealth Management reported no remaining BlackRock Health Sciences Trust position as of Q1 2017 after selling out during the quarter.
- Litman Gregory Wealth Management sold 853 BlackRock Health Sciences Trust shares in Q1 2017, an estimated $27K.
- Litman Gregory Wealth Management first reported a position in BlackRock Health Sciences Trust in Q1 2016 and held it in 4 quarters.
- Litman Gregory Wealth Management's BlackRock Health Sciences Trust position peaked at $57K in Q2 2016.
- 27 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q1 2017.
Based on Litman Gregory Wealth Management's 13F filing for Q1 2017, filed 9 May 2017.